SARS-CoV-2 antibody seroprevalence in previously undiagnosed persons in Tbilisi, Georgia: Results of three repeated serosurveys

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Rate of HCV reinfection among people living with HCV following successful DAA therapy in Tbilisi, Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

COVID-19 Challenges and Scale-up in Access to Community-based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Dynamics and peculiarities of AIDS mortality in Minsk, Belarus

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

“Evaluate potential impact of COVID-19 pandemic on HIV testing and care national program in the republic of Georgia”

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Effect of remdesivir on mortality in patients with COVID-19: A retrospective cohort study

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: An opportunity to achieve dual elimination of HIV and viral hepatitis by 2030

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of undiagnosed HBV infection in patients with COVID-19

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Obstetric complications in HIV-positive pregnant women, depending on the level of HIV RNA and CD4 count

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Post-discharge mortality among hospitalized HIV positive persons

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Outcomes of HIV pre-exposure prophylaxis (PrEP) program in Georgia for the reporting period from October 2017 to June 2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Surveillance of SARS-CoV-2 among employees of front-line healthcare facility in Tbilisi Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Incidence and residual risk of HCV in Lithuanian blood donors from 2004 to 2018: call for screening improvement in a general population

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of hyperglycemia and its impact on mortality among HIV patients in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Assessment of HCV screening and linkage to care modalities within the Georgia’s national Hepatitis C elimination program and designing the most optimal models for reaching the elimination targets

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Molecular epidemiology of Hepatitis C virus isolated from patients with newly diagnosed HCV infection in 2017-2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Surveillance of recent HIV infection in Georgia, 2018-2020

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

“ALT flare” implication into further TDF-containing chronic hepatitis B therapy effectiveness among people living with HIV

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

A series of cases of HIV and acute Hepatitis B coinfection – treatment issues

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Progress in roll-out of generic dolutegravir-based treatment in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Avidity of antibodies to Hepatitis C virus in persons with newly diagnosed HCV infection

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Latvia on its’ way to achieve WHO plan to eliminate Hepatitis C by 2030

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Co-infections with Hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern Romania

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021